JBIO CIK: 1798749

Jade Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.0
FY22:
−53.2
FY23:
−81.4
FY24:
−74.6
FY25:
−114
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−114
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.0
FY22:
−51.5
FY23:
−75.5
FY24:
−69.6
FY25:
−127
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.0
FY22:
−51.5
FY23:
−75.5
FY24:
−69.6
FY25:
−127

All amounts in millions USD Data sources:SEC EDGARTwelve Data